Table of Contents Table of Contents
Previous Page  140 / 152 Next Page
Information
Show Menu
Previous Page 140 / 152 Next Page
Page Background

S136

Abstracts / Journal of Clinical Virology 82S (2016) S1–S142

Table 1

Nucleic acid test positive CSF samples.

Viruses

n

Positive (

n

)

Positivity (%)

HSV 1

1333

24*

1.80

HSV 2

1333

1

0.08

CMV

580

19

3.28

EBV

506

22*

4.35

VZV

216

1*

0.46

HHV6

478

5*

1.05

EV

178

6

3.37

Table 2

Dual etiologic agents detected by nucleic acid test in CSF samples.

Viruses

n

HSV1 + EBV

3

HSV1 +HHV 6

1

EBV + VZV

1

EBV +HHV 6

1

Only 487 CSF samples were evaluated for EV by viral isolation

(1.1.2009–1.5.2015.) and the remaining 3291 nucleic acid tests

(NAT’s) were done from CSF samples by real time PCR for the other

viruses. Two tests, VZV and EV were done for the last one and five

years respectively.

Results:

Nucleic acid test positive CSF samples for all of the

viruses are shown in

Table 1 .

Dual infections/etiologic agents

detected are shown in

Table 2 .

Enterovirus was isolated in 30

(6.20%) of 487 CSF samples by viral culture.

When positives were evaluated viral etiology NAT positive sam-

ples were from 44.4% female and 55.6% male patients. Positive

samples came mainly from Pediatric, Neurology and Infectious dis-

eases clinics as expected. The high number of positive results were

found in samples admitted during December (35.3%), July (12.9%)

and November (10.6%). Patient age of positive samples 80% over 18

years.

Conclusion:

Positive NAT results obtained in this study with a

total of 14.39% are as other reported results world wide being <20%

when routine diagnosis is done for all CNS infections. Higher pos-

itivity rates are reported for HSV and EV, when only encephalitis

or meningitis cases are investigated. Finland’s VZV rate of 29% in

CNS infections was not observed in this (0.46%) and many other

reported studies. Nine of our 19 CMV DNA positive patients were

immunosuppressed patients as expected in CMV encephalitis. Dual

infections are predominantly seen with EBV and HHV6, that can

show a probable cause of encephalitis because of its latency in

blood cells/nervous system and ability to reactivate as well as acute

infection. Although NAT diagnostic sensitivity for HHV-6 is higher

than 95%, positive predictive value is 30% for immunocompetent

patients. Awide spectrumapproach including other herpes viruses,

adenovirus, influenza virüs, arboviruses (like WNV), measles virus,

etc., bacteria, fungi, protosoa and helmints with tecniques like

microarrays, and multiplexed methods, standardized, quality con-

trolled tests, using increased automation, quantitative approach,

supported with evidence based clinical algorithms will improve

microbiological definite diagnosis for CNS infections.

http://dx.doi.org/10.1016/j.jcv.2016.08.273

Abstract no: 183

Presentation at ESCV 2016: Poster 234

CSF: Is it possible to exclude viral infection by

cell count, protein or glucose measurement

C. Lim

, M. Turra, T. Sadlon, S. McKessar, M. Qiao,

G. Higgins

SA Pathology, Adelaide, Australia

Background:

CSF samples are usually submitted for microscopy

and bacterial culture but a decision on further testing for the pres-

ence of viruses may depend on the presence or absence of elevated

white cell counts in the sample. Normal values for total white cells

(WCC) in CSF are given as 0–5 in adults,

10 in children and

20

in neonates. However many studies have reported detecting viral

nucleic acid even when cells are absent from the CSF. Further CSF

glucose and protein levels may not be reliable predictors of under-

lying infection nor whether it is viral or bacterial. We undertook

a retrospective review of CSF samples submitted for virological

testing.

Methods:

CSF samples (

N

= 3928) submitted for virological test-

ing in the period from 1/7/2012 to 31/8/2015 were reviewed. All

samples were tested by PCR for Herpes simplex virus type 1 (HSV

1), HSV 2, Varicella zoster virus (VZV) and enterovirus, 1644 by

PCR for

Streptoccoccus pneumoniae

(Spn), 1451 by PCR for

Neisseria

meningititis

(Nmen) and 577 by latex agglutination for cryptococcal

antigen. CSF cell counts, glucose and protein levels were extracted

from the records if performed.

Results:

Of the 3928 CSF samples, enterovirus was detected

in 312 (7.9%), VZV in 77 (2.0%) HSV 1 27 (0.7%), HSV 2 29 (0.7%)

and in the smaller subsets Spn in 32 (1.9%) and Nmen 36 (2.5%).

Mean WCCs were higher in HSV 2 compared to HSV 1 infections

and mean protein levels were higher in HSV 2 and VZV than in

enterovirus infections. No cells were present in 13.4%, 11.8%, 15%,

8.3% and

10 cells were present in 32.6%, 17.6%, 30%, 8.3% of sam-

ples frompatients with detectable enterovirus, VZV, HSV 1 and HSV

2 infections respectively.

Conclusion:

Neither a cell count within the “normal range” nor

absence of a pleocytosis are able to exclude the presence of viral

nucleic acid within the CSF of patients. Protein and glucose lev-

els are not reliable in excluding viral infections. All samples from

patients with suspected meningitis should be tested for the pres-

ence of viral nucleic acid irrespective of cell counts.

http://dx.doi.org/10.1016/j.jcv.2016.08.274

Abstract no: 223

Presentation at ESCV 2016: Poster 235

Congenital rubella syndrome in a country with

high vaccination coverage – Portugal

P. Palminha

, E. Vinagre, C. Ribeiro, T. Lourenc¸ o,

C. Roque

National Institute of Health, Dr. Ricardo Jorge,

Portugal

Introduction:

The teratogenic properties of rubella virus have

been discovered in Australia in 1941 by Gregg who associated the

occurrence of rubella during pregnancy with the presence of con-

genital cataracts. Anewbornwith congenital rubella syndromemay

present major or minor malformations or be asymptomatic at birth

and later develop clinical manifestations. The introduction of the

rubella vaccine in the Portuguese National Vaccination Plan origi-

nated a decrease in the number of reported rubella and congenital